Association between polymorphisms of human positive coactivator 4 gene promoter and risk of colorectal cancer
Clinical Medicine|更新时间:2026-01-09
|
Association between polymorphisms of human positive coactivator 4 gene promoter and risk of colorectal cancer
Journal of Third Military Medical UniversityVol. 40, Issue 10, Pages: 909-917(2018)
作者机构:
1.400038 重庆,陆军军医大学(第三军医大学)军事预防医学系:军事环境卫生学教研室
2.400038 重庆,陆军军医大学(第三军医大学)军事预防医学系:毒理学研究所
作者简介:
基金信息:
the General Program of National Natural Science Foundation of China(81273156);the General Program of National Natural Science Foundation of China(30771841)
Weiyan CHEN, Qi LONG, Lingqiao WANG, et al. Association between polymorphisms of human positive coactivator 4 gene promoter and risk of colorectal cancer[J]. Journal of Third Military Medical University, 2018, 40(10): 909-917.
DOI:
Weiyan CHEN, Qi LONG, Lingqiao WANG, et al. Association between polymorphisms of human positive coactivator 4 gene promoter and risk of colorectal cancer[J]. Journal of Third Military Medical University, 2018, 40(10): 909-917. DOI: 10.16016/j.1000-5404.201801212.
Association between polymorphisms of human positive coactivator 4 gene promoter and risk of colorectal cancer
To analyze the association between potential functional single nucleotide polymorphisms (SNPs) in human positive coactivator 4 (PC4) gene promoter and the risk of colorectal cancer and assess the possibility of genetic variation of PC4 gene as a molecular marker of colorectal cancer predisposition.
Methods
2
The potential SNPs in PC4 gene promoter were selected using bioinformatic method
and Sanger sequencing and Taqman RT-PCR were used for genotyping these selected SNPs. Logistic regression analysis was performed to analyze the association between these SNPs and the risk of colorectal cancer in a case-control study involving 488 pathologically confirmed patients with colorectal cancer and 894 age-
gender
and residence-matched concurrent patients with non-malignant diseases.
Results
2
Seven potential SNPs in PC4 gene promoter were selected
among which the SNP sites rs116123859 AG+GG (
OR
=4.89
95%
CI
: 1.29~18.51
P
=0.020;
OR
adj
=3.31
95%
CI
: 0.84~13.06
P
adj
=0.087) and rs6891588 AG+GG (
OR
adj
=1.28
95%
CI
: 1.00~1.64
P
adj
=0.048) were found to be associated with the risk of colorectal cancer
but the effect was weak. The individuals carrying more risk genotypes tended to have increasing risks of colorectal cancer (
P
trend
=0.004). The results of haplotype analysis showed that the haplotypes T_C_C_G_G_A_A (
OR
=2.67
95%
CI
: 1.78~4.02
P
<
0.001) and T_G_A_G_G_G_A (
OR
=2.98
95%
CI
: 1.46~6.04
P
<
0.003) were associated an increased risk of colorectal cancer by 2 folds compared with the other haplotypes.
Conclusion
2
SNPs of PC4 gene promoter are significantly associated with the risk of colorectal cancer and can serve as a potential molecular marker of the susceptibility to colorectal cancer.
关键词
Keywords
references
TORRE LA, BRAY F, SIEGEL RL, et al . Global cancer statistics, 2012[J ] . CA Cancer J Clin, 2015, 65(2): 87-108. DOI: 10.3322/caac.21262.
KUIPERS E J, GRADY W M, LIEBERMAN D, et al . Colorectal cancer[J ] . Nat Rev Dis Primers, 2015, 1: 15065. DOI: 10.1038/nrdp.2015.65.
赫捷, 陈万青. 2012中国肿瘤登记年报[M].北京:军事医学科学出版社, 2012: 302.
HAO J, CHEN W Q. Chinese annual report of cancer in 2012[M]. Beijing: Military Medical Science Press, 2012: 302.
DRULINER BR, RUAN X, SICOTTE H, et al . Early genetic aberrations in patients with sporadic colorectal can cer[J ] . Mol Carcinog, 2018, 57(1):114-124. DOI: 10.1002/mc.22738.
MORTUSEWICZ O, ROTH W, LI N, et al . Recruitment of RNA polymerase Ⅱ cofactor PC4 to DNA damage sites[J ] . J Cell Biol, 2008, 183(5): 769-776.DOI: 10.1083/jcb.200808097.
DAS C, HIZUME K, BATTA K, et al . Transcriptional coactivator PC4, a chromatin-associated protein, induces chromatin condensation[J ] . Mol Cell Biol, 2006, 26(22): 8303-8315.DOI: 10.1128/MCB.00887-06.
SHI C, ZHU Y, ZHAU HE, et al . PC4, a novel marker for stem cell transformation and cancer progression[J ] .J Biotechnol, 2008, 136(Suppl): S189. DOI: 10.1016/j.jbiotec.2008.07.1822.
PENG Y, YANG J, ZHANG E, et al . Human positive coactivator 4 is a potential novel therapeutic target in non-small cell lung cancer[J ] . Cancer Gene Ther, 2012, 19(10): 690-696. DOI: 10.1038/cgt.2012.52.
LIAO M, ZHANG Y, KANG JH, et al . Coactivator function of positive cofactor 4 (PC4) in Sp1-directed luteinizing hormone receptor (LHR) gene transcription[J ] . J Biol Chem, 2011, 286(9): 7681-7691. DOI: 10.1074/jbc.M110.188532.
WANG X, HUANG L, XU Y, et al . Association between survivin-31G > C promoter polymorphism and cancer risk: a meta-analysis[J ] . Eur J Hum Genet, 2012, 20(7): 790-795. DOI: 10.1038/ejhg.2011.276.
CAMPBELL D B, LI C, SUTCLIFFE J S, et al . Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder[J ] . Autism Res, 2008, 1(3): 159-168. DOI: 10.1002/aur.27.
BARBER JC, HUANG S, BATEMAN MS, et al . Transmitted deletions of medial 5p and learning difficulties; does the cadherin cluster only become penetrant when flanking genes are deleted?[J ] . Am J Med Genet, 2011, 155(11): 2807-2815. DOI: 10.1002/ajmg.a.34241.
YOKOI S, YASUI K, SAITO-OHARA F, et al . A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers[J ] . Am J Pathol, 2002, 161(1): 207-216. DOI: 10.1016/S0002-9440(10)64172-7.
YANG H, ZHOU Y, ZHOU Z, et al . A novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal can cer in a southwestern Chinese population[J ] .Cancer Epidemiol Biomarkers Prev, 2009, 18(9): 2522-2527. DOI: 10.1158/1055-9965.EPI-09-0398.
ZHOU ZY, TAKEZAKI T, MO BQ, et al . Development of a semi-quantitative food frequency questionnaire to determine variation in nutrient intakes between urban and rural areas of Chongqing, China[J ] .Asia Pac J Clin Nutr, 2004, 13(3): 273-283.
ZHANG XH, SHEN M, LIU L, et al . Association analysis of single nucleotide polymorphisms in C1QTNF6, RAC2, and an intergenic region at 14q32.2 with Graves' Disease in Chinese Han population[J ] .Genet Test Mol Biomarkers, 2017, 21(8): 479-484. DOI: 10.1089/gtmb.2017.0009.
NAMIPASHAKI A, RAZAGHI-MOGHADAM Z, ANSARI-POUR N. The essentiality of reporting Hardy-Weinberg equilibrium calculations in population-based genetic association studies[J]. Cell J, 2015, 17(2): 187-192. DOI: 10.22074/cellj.2016.3711.
QIAN D, ZHANG B, ZENG XL, et al . Inhibition of human positive cofactor 4 radiosensitizes human esophageal squmaous cell carcinoma cells by suppressing XLF-mediated nonhomologous end joining[J ] . Cell Death Dis, 2014, 5: e1461.DOI: 10.1038/cddis.2014.416.
HU X, ZHANG C, ZHANG Y, et al . Down regulation of human positive coactivator 4 suppress tumorigenesis and lung metastasis of osteosarcoma[J ] . Oncotarget, 2017, 8: 53210-53225. DOI: 10.18632/oncotarget.18290.
LI S Y, LANG Z H, HUANG D F. Research progress on eukaryotic promoter[J]. Current Biotech, 2014, 4(3): 158-164. DOI:10.3969/j.issn.2095-2341.2014.03.02.
CONESA C, ACKER J.Sub1/PC4 a chromatin associated protein with multiple functions in transcriptionp[J]. RNA Biol, 2010, 7(3): 287-290. DOI: 10.4161/rna.7.3.11491.
HOOKER S, BONILLA C, AKEREYENI F, et al . NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans[J ] . Prostate Cancer Prostatic Dis, 2008, 11(4): 349-356. DOI: 10.1038/sj.pcan.4501027.
HOWELL W M, JOBS M, GYLLENSTEN U, et al . Dynamic allele-specific hybridization. A newmethod for scoring single nucleotide polymorphisms[J ] . Nat Biotechnol, 1999, 17(1): 87-88. DOI: 10.1038/5270.
MiR-543/SNTB1 axis modulates immune microenvironment in colorectal cancer
Efficacy and safety of immunotherapy combined with targeted therapy and chemotherapy in third-line treatment of microsatellite stable metastatic colorectal cancer
Preparation of nanosized hypoxia-inducible factor 1α inhibitor and its application in reversing chemoresistance in colorectal cancer cells
Association of Rab37 gene polymorphism and delayed menarche: a report of 2 060 women
Plateau hypoxia improves tumor immune microenvironment and inhibits subcutaneous tumor growth of colorectal cancer
Related Author
ZHANG Min
LI Min
XIAO Meng
CHEN Cai
ZHENG Xiaoju
LEI Yuguang
ZHAO Wensi
SONG Jian
Related Institution
School of Medicine, Xinyang Hospital of Traditional Chinese Medicine
School of Pharmaceutical Sciences, Xinyang Vocational and Technical College, Xinyang, Henan, Xinyang Hospital of Traditional Chinese Medicine
Department of Pathology, Xinyang Hospital of Traditional Chinese Medicine
Department of Oncology, Renmin Hospital of Wuhan University
Department of Pharmacy, Renmin Hospital of Wuhan University